Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Directional Capital to acquire Pizza Hut UK operations
Directional Capital, a private equity firm, is in advanced discussions to acquire Pizza Hut UK’s restaurant operations. The proposed deal would include 140 sites and save most of the 3,000 jobs tied to the business. Only a small number of outlets are expected to...
Top 3 private equity news of the week
Prada is evaluating a potential acquisition of Versace from Capri Holdings, with Citi acting as its adviser. Capri Holdings has engaged Barclays to identify potential buyers for Versace, attracting interest from private equity funds and other fashion groups. This...
PE-backed Diagnostyka targets $1.2bn valuation with Warsaw IPO
Polish laboratory operator Diagnostyka SA, backed by private equity firm Mid Europa Partners, is gearing up for an IPO on the Warsaw Stock Exchange. The offering will feature shares held by Mid Europa, which owns a 47.83% stake in the company. Market estimates suggest...